Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–7.

Article  CAS  PubMed  Google Scholar 

Siegel RL, Giaquinto AN, Jemal AJC. Cancer statistics, 2024. 2024.

La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F. Negri EJIjoc: thyroid cancer mortality and incidence: a global overview. 2015, 136(9):2187–95.

Tran Q-L, Davies LJCOE, Research M. Thyroid Cancer Incidence Differences between Men Women. 2023:100472.

Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505–27.

Article  PubMed  Google Scholar 

Salehiniya H, Pakzad R, Hassanipour S, Mohammadian M. The incidence and mortality of thyroid cancer and its relationship with HDI in the world. World Cancer Res J. 2018;5(2):1–6.

Google Scholar 

Sipos J, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol. 2010;22(6):395–404.

Article  CAS  Google Scholar 

Bendouida A, Moulessehoul S, Harir N, Rih A, Diaf M, Belhandouze L. Epidemiology, diagnosis and treatement of thyroid cancer in Western Algeria (Sidi Bel Abbes region). J Africain Du Cancer/African J Cancer. 2015;7:213–7.

Article  Google Scholar 

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Cancer J Clin. 2005;55(2):74–108.

Article  Google Scholar 

Goodarzi E, Moslem A, Feizhadad H, Jarrahi AM, Adineh HA, Sohrabivafa M, Khazaei Z. Epidemiology, incidence and mortality of thyroid cancer and their relationship with the human development index in the world: an ecology study in 2018. Adv Hum Biology. 2019;9(2):162–7.

Article  Google Scholar 

Programa de las Naciones Unidas para el Desarrollo (UNDP) Human Development Report. 2016. Human Development for Everyone. New York, USA: United Nations Development Programme, 1 UN Plaza;. [https://sustainabledevelopment.un.org/content/documents/25212016_human_development_report.pdf].

United Nations Development Programme (UNDP). Human Development Indicators and Indices: 2018 Statistical Update Team. New York, USA: United Nations Development Programme, 1 UN Plaza;. [https://hdr.undp.org/content/statistical-update-2018].

Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13(8):790–801.

Article  PubMed  Google Scholar 

Herrera-Serna BY, Lara-Carrillo E, Toral-Rizo VH, do Amaral RC, Aguilera-Eguía RA. Relationship between the human development index and its components with oral cancer in Latin America. J Epidemiol Global Health. 2019;9(4):223.

Article  Google Scholar 

Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res Perspect. 2016;7(6):360–72.

Article  PubMed  PubMed Central  Google Scholar 

Rafiemanesh H, Mehtarpour M, Khani F, Hesami SM, Shamlou R, Towhidi F, Salehiniya H, Makhsosi BR, Moini A. Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Disease. 2016;8(6):1094.

Article  Google Scholar 

Khazaei Z, Goodarzi E, Borhaninejad V, Iranmanesh F, Mirshekarpour H, Mirzaei B, Naemi H, Bechashk SM, Darvishi I, Ershad Sarabi RJBPH. The association between incidence and mortality of brain cancer and human development index (HDI): an ecological study. 2020, 20(1):1–7.

Khazaei Z, Namayandeh SM, Beiranvand R, Naemi H, Bechashk SM. Goodarzi EJJopm, hygiene: Worldwide incidence and mortality of ovarian cancer and Human Development Index (HDI): GLOBOCAN sources and methods 2018. 2021, 62(1):E174.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. 2013. In.; 2014.

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology 2013, 2013.

McBride GJNcrH-. A proposal for strength-of-agreement criteria for Lin’s concordance correlation coefficient. 2005, 45:307–10.

Dehghan A, Khanjani N, Bahrampour A, Goudarzi G, Yunesian MJB. The relation between air pollution and respiratory deaths in Tehran, Iran-using generalized additive models. 2018, 18(1):1–9.

Ethan CJ, Mokoena KK, Yu Y, Shale K, Fan Y, Rong J, Liu FJES, Research P. Association between PM 2.5 and mortality of stomach and colorectal cancer in Xi’an: a time-series study. 2020, 27:22353–63.

Maleki Z, Hassanzadeh J, Méndez-Arriaga F, Ghaem HJES, Research P. Environmental factors and incidence of thyroid cancer in the world (1990–2019): an ecological study. 2023, 30(44):100072–7.

Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and mortality of breast Cancer and their relationship with the Human Development Index (HDI) in the World in 2012. Asian Pac J Cancer Prev. 2016;16(18):8439–43.

Article  Google Scholar 

Udelsman R, Zhang YJT. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. 2014, 24(3):472–9.

Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi SJT. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. 2015, 25(10):1127–36.

Hall SF, Irish J, Groome P, Griffiths RJCM. Access, excess, and overdiagnosis: the case for thyroid cancer. 2014, 3(1):154–61.

Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EYJC. Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans affairs health care system. 2015, 121(5):741–6.

Liu H, Wang X, Yang R, Zeng W, Peng D, Li J, Wang HJB. Recent development of nuclear molecular imaging in thyroid cancer. 2018, 2018.

Palot Manzil FF, Kaur H. Radioactive Iodine for Thyroid Malignancies. In: StatPearls edn. Treasure Island (FL) relationships with ineligible companies. Disclosure: Harleen Kaur declares no relevant financial relationships with ineligible companies.: StatPearls Publishing Copyright © 2024, StatPearls Publishing LLC.; 2024.

Li N, Du XL, Reitzel LR, Xu L, Sturgis EMJT. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980–2008. 2013, 23(1):103–10.

Yang L, Shen W, Sakamoto N. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol. 2013;31(4):468–74.

Article  PubMed  Google Scholar 

Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, Xu P, Yang S, Zhai Z, Zhou L. Global burden of thyroid cancer from 1990 to 2017. JAMA Netw open. 2020;3(6):e208759–208759.

Article  PubMed  PubMed Central  Google Scholar 

Bao WQ, Zi H, Yuan QQ, Li LY, Deng T. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer. 2021;12(18):2494–503.

Article  PubMed  PubMed Central  Google Scholar 

Azadnajafabad S, Saeedi Moghaddam S, Mohammadi E, Rezaei N, Ghasemi E, Fattahi N, Aminorroaya A, Azadnajafabad R, Aryannejad A, Rezaei N. Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: a systematic analysis of the global burden of Disease Study 1990–2017. Cancer Med. 2021;10(7):2496–508.

Article  PubMed  PubMed Central  Google Scholar 

Zevallos JP, Xu L, Yiu YJT. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. 2014, 24(4):758–63.

Jabin Z, Kwon SY, Bom H-S, Lin Y, Yang K, Inaki A, Dewi AR, Al-Ibraheem AN, Al Balooshi B, San Luis TOJNMC Jr. Clinico-social factors to choose radioactive iodine dose in differentiated thyroid cancer patients: an Asian survey. 2018, 39(4):283–9.

Al-Ibraheem A, Al-Rasheed U, Mashhadani N, Abdlkadir AS, Al-Adhami DA, Ruzzeh S, Istatieh F, Mansour A, Hamdan B, Kheetan RJC. Long-term survival analysis and prognostic factors of arabic patients with differentiated thyroid carcinoma: a 20-Year observational study at the King Hussein Cancer Center (KHCC) Involving 528 patients. 2023, 15(16):4102.

Harari A, Li N, Yeh MWJTJCE. Metabolism: racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. 2014, 99(1):133–41.

Al-Ibraheem A, Al-Shammaa M, Abdlkadir AS, Istatieh F, Al-Rasheed U, Pascual T, Rihani R, Halalsheh H, Ismael T, Khalaf AJL. Survival Trends in Pediatric Differentiated Thyroid Cancer: A Middle Eastern Perspective. 2024, 14(1):158.